ClearPoint Neuro (CLPT) Operating Income Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -14.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.07% |
| Dec 31, 2025 | -16.38% |
| Sep 30, 2025 | -11.61% |
| Jun 30, 2025 | -10.55% |
| Mar 31, 2025 | -16.84% |
| Dec 31, 2024 | -12.28% |
| Sep 30, 2024 | -10.68% |
| Jun 30, 2024 | -11.51% |
| Mar 31, 2024 | -24.57% |
| Dec 31, 2023 | -27.60% |
| Sep 30, 2023 | -56.73% |
| Jun 30, 2023 | -69.09% |
| Mar 31, 2023 | -67.80% |
| Dec 31, 2022 | -46.61% |
| Sep 30, 2022 | -60.93% |
| Jun 30, 2022 | -48.14% |
| Mar 31, 2022 | -58.40% |
| Dec 31, 2021 | -59.63% |
| Sep 30, 2021 | -46.65% |
| Jun 30, 2021 | -27.70% |
| Mar 31, 2021 | -15.19% |
| Sep 30, 2019 | 18.94% |
| Jun 30, 2019 | 14.31% |
| Mar 31, 2019 | 20.48% |
| Sep 30, 2018 | 14.46% |
| Jun 30, 2018 | 15.20% |
| Mar 31, 2018 | 21.45% |
| Sep 30, 2016 | 2.79% |
| Jun 30, 2016 | 1.92% |
| Mar 31, 2016 | -12.26% |
| Sep 30, 2015 | -23.74% |
| Jun 30, 2015 | -77.52% |
| Mar 31, 2015 | -36.75% |
| Dec 31, 2014 | -26.88% |
| Sep 30, 2014 | -22.32% |
| Jun 30, 2014 | -14.60% |
| Mar 31, 2014 | 48.64% |